Science Explorer Interactive view Map
Company · Tokyo · Japan

Novartis (Japan)

In research, Novartis (Japan) stands highest in Medicine (#13,644 of 17,978 worldwide) and Health Sciences (#16,744 of 20,462 worldwide), over all time.

novartis.co.jpROR OpenAlex
World rank, all time
#34,087
of 42,892
Rank in Japan
#1,444
of 2,112
Research works
210
▲ 98% vs 2013–17
Citations
4.5k
21.3 per fractional work
Top-10% rate
9.2%
record average 16.5%
Open access
52%
world 28%

What is Novartis (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #13,644 of 17,978 14.1%124
Health SciencesDomain #16,744 of 20,462 14.3%127

Each strip is that field’s whole ranked pool, with the notch where Novartis (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.73× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.89× its world share, 3 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.54× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.26× its world share, 0 worksChemistryComputer Science: 0.20× its world share, 1 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.82× its world share, 0 worksMathematicsHealth Professions: 0.35× its world share, 0 worksHealth ProfessionsMedicine: 3.60× its world share, 28 worksMedicineNursing: 1.33× its world share, 0 worksNursingDecision Sciences: 0.22× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.24× its world share, 2 worksEconomics, Econometr…Social Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.9×. Every wedge is a field page.

Which keywords describe research at Novartis (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Inflammation, Diagnosis, Treatment, Immune Response, Quality of Life, Clinical Trials and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Epidemiology6▲ 3.8×18 topics
  2. Inflammation4▲ 5.2×13 topics
  3. Diagnosis3▲ 8.9×12 topics
  4. Treatment3▲ 5.8×9 topics
  5. Quality of Life3▲ 4.6×5 topics
  6. Immune Response2▲ 10.0×4 topics
  7. Cardiovascular Disease2▲ 4.7×10 topics
  8. Clinical Trials2▲ 7.6×7 topics
  9. Immunotherapy2▲ 7.1×6 topics
  10. Heart Failure2▲ 11×7 topics
  11. Asthma2▲ 46×2 topics
  12. Autoantibodies2▲ 18×5 topics
  13. Lymphoma2▲ 26×2 topics
  14. CAR T Cells2▲ 54×1 topic
  15. Chimeric Antigen Receptor2▲ 54×1 topic
  16. Immune Dysregulation2▲ 47×2 topics
  17. Genetics1▲ 5.1×3 topics
  18. Immune System1▲ 14×2 topics
  19. Filaggrin1▲ 67×1 topic
  20. Management1▲ 4.2×7 topics
  21. Skin Microbiome1▲ 67×1 topic
  22. Cost-effectiveness Analysis1▲ 37×1 topic
  23. Health Utility Measures1▲ 37×1 topic
  24. Immunosuppressive Therapy1▲ 16×5 topics
  25. TGF-ß1▲ 19×3 topics
  26. Autoimmune1▲ 60×2 topics
  27. Chemotherapy1▲ 3.9×7 topics
  28. Clinical Guidelines1▲ 9.2×4 topics
  29. Hypertension1▲ 9.1×5 topics
  30. IL-171▲ 82×1 topic
  31. Optical Coherence Tomography1▲ 27×2 topics
  32. Public Health1▲ 1.97×4 topics
  33. Regulatory T Cells1▲ 25×2 topics
  34. TH17 Cells1▲ 82×1 topic
  35. Global Burden1▲ 4.8×3 topics
  36. Intravenous Immunoglobulin1▲ 40×2 topics
  37. Macular Degeneration1▲ 21×3 topics

Which research topics does Novartis (Japan) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Dermatology and Skin Diseases, Health Systems, Economic Evaluations, Quality of Life and Psoriasis: Treatment and Pathogenesis.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksDermatology and Skin Dis…1Dermatology and Skin Diseases: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksRespiratory and Cough-Related Research: 1 fractional worksAsthma and respiratory diseases: 1 fractional worksRetinal and Optic Conditions: 1 fractional worksMelanoma and MAPK Pathways1Melanoma and MAPK Pathways: 1 fractional worksInflammasome and immune disorders: 1 fractional worksAllergic Rhinitis and Sensitization: 1 fractional works
OncologyDermatologyEconomics and EconometricsImmunology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Dermatology and Skin Diseases Dermatology 1 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  4. 4 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  5. 5 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
  6. 6 Asthma and respiratory diseases Physiology 1 works
  7. 7 Retinal and Optic Conditions Ophthalmology 1 works
  8. 8 Melanoma and MAPK Pathways Molecular Biology 1 works
  9. 9 Inflammasome and immune disorders Molecular Biology 1 works
  10. 10 Allergic Rhinitis and Sensitization Immunology and Allergy 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.5%not open48.5%

World: 28% of research is openly available.

with international co-authors34.0%domestic only66.0%

World: 19% is written across borders.

How has Novartis (Japan)'s research output changed?

Output in 2018–2022 was 98% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.